Anturane is indicated for the treatment of: Chronic gouty arthritis Intermittent gouty arthritis

---

Gouty Arthritis -- Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular.

Patients with an active peptic ulcer or symptoms of gastrointestinal inflammation or ulceration should not receive the drug.

      The drug is contraindicated in patients with a history or the presence of: Hypersensitivity to phenylbutazone or other pyrazoles Blood dyscrasias

---

Active Peptic Ulcer --

Symptoms -- An indication that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.

Ulcer -- A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.

Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

Hematological Disease -- Disorders of the blood and blood forming tissues.

Studies on the teratogenicity of pyrazole compounds in animals have yielded inconclusive results.

Up to the present time, however, there have been no reported cases of human congenital malformation proved to be due to the use of the drug.      It is suggested that Anturane be used with caution in pregnant women, weighing the potential risks against the possible benefits.